Data search


search
Exact
Search

Results for MligTC455_13897

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_13897 26 0.54 Mlig455_007882

Neo: -

Age: -

Mlig455_007882 {REF} {Length: 1288} {RNA1310_105239.2} {RNA815_16034.1}

Cumulative graph for MligTC455_13897

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 0 1.076 0.99982 1.00000
RegionR2 0.188 1.076 0.54817 0.91411
RegionR3 0.962 1.076 0.32122 0.85891
RegionR4 0.609 1.076 0.99975 1.00000
RegionR5 -0.719 1.076 0.99982 1.00000
RegionR6 0.907 1.076 0.32499 0.91365
RegionR7 -1.331 1.076 0.99985 1.00000
RegionR8 -0.617 1.076 0.99983 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -1.445 1.076 1.00000 1.00000
RegenerationR2 1.624 1.076 0.18230 0.62564
RegenerationR3 0.946 1.076 0.68940 0.94420
RegenerationR4 1.943 1.076 0.15651 0.58777
RegenerationR5 1.961 1.076 0.15819 0.58026
RegenerationR6 1.19 1.076 0.54577 0.83666
RegenerationBL -1.813 1.076 0.99987 1.00000
RegenerationTP 1.982 1.076 0.49577 0.89797


Genes with expression patterns similar to MligTC455_13897

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_13897 26 0.54 Mlig455_007882

Neo: -

Age: -

2 - - - - 1.000 1.000 Mlig455_007882 {REF} {Length: 1288} {RNA1310_105239.2} {RNA815_16034.1}
2. MligTC455_48258 34 0.71 Mlig455_020899

Neo: -

Age: Down-Down-Up

VAV3 0.994 - - - - 0.994 - Mlig455_020899 {REF} {Length: 3371} {Pfam: Calponin homology (CH) domain [PF00307.33, score=42.1]; RhoGEF domain [PF00621.22, score=39.9]; SH2 domain [PF00017.26, score=27.7]; CAMSAP CH domain [PF11971.10, score=19.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=18.8]} {Human: ENSG00000134215, VAV3, vav guanine nucleotide exchange factor 3, [Score=142, Expect=3e-34]; ENSG00000160293, VAV2, vav guanine nucleotide exchange factor 2, [Score=141, Expect=5e-34]} {Mouse: ENSMUSG00000009621, Vav2, vav 2 oncogene, [Score=140, Expect=6e-34]; ENSMUSG00000033721, Vav3, vav 3 oncogene, [Score=139, Expect=1e-33]} {Celegans: WBGene00006887, vav-1, [Score=109, Expect=4e-24]} {Smed: dd_Smed_v6_6109_0_1, dd_Smed_v6_6109_0_1, [Score=96.7, Expect=2e-20]} {RNA1310_24185} {RNA815_29420}
3. MligTC455_40648 60 1.24 Mlig455_034479

Neo: -

Age: Down-Up-Up

0.987 - - - - 0.987 - Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590}
4. MligTC455_15589 7 0.14 Mlig455_018037

Neo: -

Age: Down-Up-Down

0.986 - - - - 0.986 - Mlig455_018037 {REF} {Length: 3443} {TRANSSPLICED} {Smed: dd_Smed_v6_6099_0_1, dd_Smed_v6_6099_0_1, [Score=87.8, Expect=2e-19]} {RNA1509_9501} {RNA1310_8454} {RNA815_6408}
5. MligTC455_43925 14 0.28 Mlig455_007983

Neo: -

Age: -

0.986 - - - - 0.986 - Mlig455_007983 {REF} {Length: 2821} {RNA1310_91563}
6. MligTC455_52746 33 0.7 Mlig455_036774

Neo: -

Age: -

0.984 - - - - 0.984 - Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348}
7. MligTC455_52164 49 1.01 Mlig455_019248

Neo: -

Age: Down-Up-Up

Region-enriched R1: 12.972/0.02781
Region-enriched R4: 6.179/0.01048

0.981 - - - - 0.981 - Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298}
8. MligTC455_45063 105 2.19 Mlig455_045829, Mlig455_045845, Mlig455_045862

Neo: -

Age: -

0.979 - - - - 0.979 -

Mlig455_045829 {REF} {Length: 4186} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865}

Mlig455_045845 {REF} {Length: 3433} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=101, Expect=1e-22]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865}

Mlig455_045862 {REF} {Length: 3524} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1, RNA1509_43949} {RNA1509_43949, RNA815_26865}
9. MligTC455_18492 32 0.68 Mlig455_026506

Neo: -

Age: -

ADRA1B 0.978 - - - - 0.978 - Mlig455_026506 {REF} {Length: 1747} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=271.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=40.7]} {Human: ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=244, Expect=8e-74]} {Mouse: ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=242, Expect=3e-73]} {Dmel: FBgn0266137, Dop1R2, Dopamine 1-like receptor 2, [RH, Score=310, Expect=2e-96]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_22802_0_1, dd_Smed_v6_22802_0_1, [RH, Score=325, Expect=9e-107]} {RNA1310_108893}
10. MligTC455_19097 120 2.49 Mlig455_035179

Neo: -

Age: -

Region-enriched R2: 5.873/0.00339
Region-enriched R3: 5.589/0.00004

KCNK3 0.976 - - - - 0.976 - Mlig455_035179 {REF} {Length: 2899} {Pfam: Ion channel [PF07885.18, score=103.1]; Ion transport protein [PF00520.33, score=23.8]} {Human: ENSG00000171303, KCNK3, potassium two pore domain channel subfamily K member 3, [Score=67.0, Expect=5e-11]; ENSG00000169427, KCNK9, potassium two pore domain channel subfamily K member 9, [Score=65.9, Expect=1e-10]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=72.4, Expect=6e-13]} {Dmel: FBgn0033257, sand, sandman, [Score=105, Expect=4e-24]} {Celegans: WBGene00006690, twk-39, TWiK family of potassium channels, [RH, Score=117, Expect=4e-27]} {Smed: dd_Smed_v6_21895_0_1, dd_Smed_v6_21895_0_1, [RH, Score=188, Expect=7e-51]} {RNA1310_31604} {RNA815_54785}
11. MligTC455_52726 213 4.44 Mlig455_032119

Neo: -

Age: -

Region-enriched R2: 4.573/0.00005

0.974 - - - - 0.974 - Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1}
12. MligTC455_26832 211 4.39 Mlig455_000690

Neo: -

Age: Down-Up-Down

ANK3 0.973 - - - - 0.973 - Mlig455_000690 {REF} {Length: 2225} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=184.0]; Ankyrin repeats (many copies) [PF13637.8, score=128.0]; Ankyrin repeat [PF00023.32, score=96.2]; Ankyrin repeats (many copies) [PF13857.8, score=94.5]; Ankyrin repeat [PF13606.8, score=92.4]; SOCS box [PF07525.18, score=29.0]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=120, Expect=6e-28]; ENSG00000135299, ANKRD6, ankyrin repeat domain 6, [Score=119, Expect=7e-28]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=122, Expect=1e-28]; ENSMUSG00000040183, Ankrd6, ankyrin repeat domain 6, [Score=122, Expect=6e-29]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=121, Expect=1e-28]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=97.4, Expect=6e-21]} {Smed: dd_Smed_v6_17293_0_1, dd_Smed_v6_17293_0_1, [RH, Score=549, Expect=0.0]} {RNA1509_43489} {RNA1310_16486.1} {RNA815_13229}
13. MligTC455_45231 73 1.52 Mlig455_027244

Neo: -

Age: Up-Down-Down

SLC16A14 0.973 - - - - 0.973 - Mlig455_027244 {REF} {Length: 2892} {Pfam: Major Facilitator Superfamily [PF07690.18, score=114.7]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [Score=148, Expect=8e-38]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [Score=146, Expect=3e-37]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=312, Expect=1e-97]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=301, Expect=7e-94]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=198, Expect=1e-55]} {RNA1310_24115} {RNA815_15685}
14. MligTC455_15712 181 3.76 Mlig455_030495

Neo: -

Age: -

Region-enriched R8: 3.854/0.00430

PAX6 0.972 - - - - 0.972 - Mlig455_030495 {REF} {Length: 4633} {Pfam: 'Paired box' domain [PF00292.20, score=231.0]; Homeodomain [PF00046.31, score=76.2]; Homeodomain-like domain [PF13384.8, score=21.2]} {Human: ENSG00000007372, PAX6, paired box 6, [RH, Score=259, Expect=5e-80]} {Mouse: ENSMUSG00000027168, Pax6, paired box 6, [RH, Score=258, Expect=2e-78]} {Dmel: FBgn0019650, toy, twin of eyeless, [RH, Score=243, Expect=6e-72]} {Celegans: WBGene00006870, vab-3, MAB-18, [RH, Score=236, Expect=2e-70]} {Smed: dd_Smed_v6_17726_0_1, dd_Smed_v6_17726_0_1, [RH, Score=431, Expect=9e-144]} {RNA1310_37223} {RNA815_52287.1}
15. MligTC455_43486 59 1.22 Mlig455_056889

Neo: -

Age: Up-Down-Down

RCVRN 0.972 - - - - 0.972 - Mlig455_056889 {REF} {Length: 1808} {Pfam: EF-hand domain pair [PF13499.8, score=46.2]; EF hand [PF00036.34, score=42.1]; EF-hand domain [PF13405.8, score=40.1]; EF hand [PF13202.8, score=18.6]} {Human: ENSG00000109047, RCVRN, recoverin, [Score=51.6, Expect=4e-08]; ENSG00000138472, GUCA1C, guanylate cyclase activator 1C, [Score=50.4, Expect=1e-07]} {Mouse: ENSMUSG00000020907, Rcvrn, recoverin, [Score=48.9, Expect=2e-07]} {Smed: dd_Smed_v6_6534_0_2, dd_Smed_v6_6534_0_2, [Score=48.5, Expect=1e-07]} {RNA1509_37879} {RNA1310_35664, RNA1509_37879} {RNA1509_37879, RNA815_32400}
16. MligTC455_42365 56 1.17 Mlig455_037334

Neo: -

Age: -

CHRNA3 0.971 - - - - 0.971 - Mlig455_037334 {REF} {Length: 3103} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=226.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=224.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=376, Expect=9e-124]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=372, Expect=2e-122]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=360, Expect=9e-118]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=382, Expect=2e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=374, Expect=2e-123]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=451, Expect=2e-153]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=384, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [RH, Score=660, Expect=0.0]} {RNA1509_45903} {RNA1310_11151} {RNA815_10044.1}
17. MligTC455_11822 10 0.22 Mlig455_037067

Neo: -

Age: -

0.97 - - - - 0.970 - Mlig455_037067 {REF} {Length: 680} {RNA1310_11581.1} {RNA815_17912}
18. MligTC455_35275 40 0.84 Mlig455_039117

Neo: -

Age: -

0.97 - - - - 0.970 - Mlig455_039117 {REF} {Length: 2535} {RNA1310_18660} {RNA815_15449}
19. MligTC455_39632 71 1.48 Mlig455_039338

Neo: -

Age: Up-Down-Down

Region-enriched R2: 4.404/0.02299

APBA1 0.97 - - - - 0.970 - Mlig455_039338 {REF} {Length: 5781} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=122.8]; PDZ domain [PF00595.26, score=87.0]; PDZ domain [PF17820.3, score=50.7]} {Human: ENSG00000107282, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=476, Expect=5e-157]; ENSG00000276497, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=474, Expect=2e-161]; ENSG00000276495, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]; ENSG00000034053, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]} {Mouse: ENSMUSG00000030519, Apba2, amyloid beta (A4) precursor protein-binding, family A, member 2, [RH, Score=476, Expect=3e-158]; ENSMUSG00000024897, Apba1, amyloid beta (A4) precursor protein binding, family A, member 1, [RH, Score=475, Expect=2e-156]} {Dmel: FBgn0052677, X11Lbeta, [Score=532, Expect=2e-168]} {Celegans: WBGene00002999, lin-10, [Score=519, Expect=1e-172]} {Smed: dd_Smed_v6_2836_0_2, dd_Smed_v6_2836_0_2, [Score=550, Expect=0.0]} {RNA1509_43941, RNA1509_55204} {RNA1310_18864.1, RNA1509_43941} {RNA1509_43941, RNA815_11653}
20. MligTC455_43201 71 1.49 Mlig455_004169, Mlig455_004193

Neo: -

Age: Down-Up-Up

0.969 - - - - 0.969 -

Mlig455_004169 {REF} {Length: 1823} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=74.3, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243}

Mlig455_004193 {REF} {Length: 1806} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243}
21. MligTC455_23046 38 0.8 Mlig455_070735

Neo: -

Age: -

0.968 - - - - 0.968 - Mlig455_070735 {REF} {Length: 573} {NoTransDecoderORF} {RNA1310_101740}
22. MligTC455_40649 24 0.49 Mlig455_066232

Neo: -

Age: -

0.968 - - - - 0.968 - Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590}
23. MligTC455_44051 392 8.18 Mlig455_008770, Mlig455_008804

Neo: -

Age: -

Regeneration-downregulated BL: -5.343

Regeneration-depleted BL: -5.343

IPMK 0.968 - - - - 0.968 -

Mlig455_008770 {REF} {Length: 3071} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=104.2]} {Human: ENSG00000151151, IPMK, inositol polyphosphate multikinase, [Score=112, Expect=8e-27]} {Mouse: ENSMUSG00000060733, Ipmk, inositol polyphosphate multikinase, [Score=106, Expect=4e-25]} {Dmel: FBgn0031267, Ipk2, [Score=111, Expect=1e-27]} {Celegans: WBGene00014081, impk-1, Kinase, [Score=71.2, Expect=1e-13]} {Smed: dd_Smed_v6_3701_0_1, dd_Smed_v6_3701_0_1, [Score=150, Expect=3e-42]} {RNA1509_8202} {RNA1310_21614.2} {RNA815_34405}

Mlig455_008804 {REF} {Length: 2051} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=103.9]} {Human: ENSG00000151151, IPMK, inositol polyphosphate multikinase, [Score=112, Expect=4e-27]} {Mouse: ENSMUSG00000060733, Ipmk, inositol polyphosphate multikinase, [Score=107, Expect=1e-25]} {Dmel: FBgn0031267, Ipk2, [Score=113, Expect=2e-28]} {Celegans: WBGene00014081, impk-1, Kinase, [Score=71.2, Expect=9e-14]} {Smed: dd_Smed_v6_3701_0_1, dd_Smed_v6_3701_0_1, [Score=150, Expect=2e-42]} {RNA1509_8202} {RNA1310_21614.2} {RNA815_34405}
24. MligTC455_12438 17 0.35 Mlig455_009594

Neo: -

Age: -

0.967 - - - - 0.967 - Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274}
25. MligTC455_26101 65 1.35 Mlig455_036947

Neo: -

Age: -

0.967 - - - - 0.967 - Mlig455_036947 {REF} {Length: 2415} {RNA1509_51525} {RNA1310_9237.1} {RNA815_5309}
26. MligTC455_50328 128 2.66 Mlig455_039843

Neo: -

Age: -

SCNN1B 0.967 - - - - 0.967 - Mlig455_039843 {REF} {Length: 2793} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=206.6]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=69.3, Expect=1e-11]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=58.9, Expect=1e-08]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=75.5, Expect=8e-14]} {Smed: dd_Smed_v6_23028_0_1, dd_Smed_v6_23028_0_1, [RH, Score=366, Expect=3e-118]} {RNA1509_37054} {RNA1310_10450, RNA1509_37054} {RNA1509_37054, RNA815_17111}
27. MligTC455_53276 52 1.07 Mlig455_032898

Neo: -

Age: -

0.967 - - - - 0.967 - Mlig455_032898 {REF} {Length: 473} {NoTransDecoderORF} {RNA1310_127585} {RNA815_54104}
28. MligTC455_38271 28 0.58 Mlig455_007218, Mlig455_007452

Neo: -

Age: -

NMBR 0.966 - - - - 0.966 -

Mlig455_007218 {REF} {Length: 2883} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=39.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=29.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.1]} {Human: ENSG00000135577, NMBR, neuromedin B receptor, [Score=109, Expect=7e-26]; ENSG00000182687, GALR2, galanin receptor 2, [Score=109, Expect=7e-26]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=107, Expect=6e-25]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=104, Expect=3e-24]; ENSMUSG00000025905, Oprk1, opioid receptor, kappa 1, [Score=103, Expect=5e-24]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=102, Expect=1e-23]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=101, Expect=4e-23]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=116, Expect=9e-28]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=89.7, Expect=2e-19]} {Smed: dd_Smed_v6_16861_0_1, dd_Smed_v6_16861_0_1, [Score=129, Expect=2e-33]} {RNA1509_59962} {RNA1310_93226} {RNA815_13947}

Mlig455_007452 {REF} {Length: 2739} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=39.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=29.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.1]} {Human: ENSG00000135577, NMBR, neuromedin B receptor, [Score=109, Expect=7e-26]; ENSG00000182687, GALR2, galanin receptor 2, [Score=109, Expect=7e-26]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=107, Expect=6e-25]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=104, Expect=3e-24]; ENSMUSG00000025905, Oprk1, opioid receptor, kappa 1, [Score=103, Expect=5e-24]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=102, Expect=1e-23]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=101, Expect=4e-23]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=116, Expect=9e-28]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=89.7, Expect=2e-19]} {Smed: dd_Smed_v6_16861_0_1, dd_Smed_v6_16861_0_1, [Score=129, Expect=2e-33]} {RNA1509_59962} {RNA1310_93226} {RNA815_13947}
29. MligTC455_38279 69 1.44 Mlig455_045200

Neo: -

Age: -

NOL4L 0.966 - - - - 0.966 - Mlig455_045200 {REF} {Length: 1997} {Human: ENSG00000197183, NOL4L, nucleolar protein 4 like, [RH, Score=150, Expect=9e-40]} {Mouse: ENSMUSG00000061411, Nol4l, nucleolar protein 4-like, [RH, Score=150, Expect=1e-39]} {Dmel: FBgn0283651, CG46301, [RH, Score=147, Expect=2e-37]} {Smed: dd_Smed_v6_27580_0_1, dd_Smed_v6_27580_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1310_76365.1} {RNA815_48196}
30. MligTC455_38928 28 0.59 Mlig455_046983

Neo: -

Age: -

0.965 - - - - 0.965 - Mlig455_046983 {REF} {Length: 445} {NoTransDecoderORF} {RNA1509_25556} {RNA1310_73151} {RNA815_48752}
31. MligTC455_29317 89 1.85 Mlig455_062533

Neo: -

Age: logFC(26M/2M)=0.866

SLC18A3 0.964 - - - - 0.964 - Mlig455_062533 {REF} {Length: 3319} {Pfam: Major Facilitator Superfamily [PF07690.18, score=140.0]; LacY proton/sugar symporter [PF01306.21, score=22.0]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=457, Expect=1e-155]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=462, Expect=8e-158]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=512, Expect=6e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=474, Expect=6e-163]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=535, Expect=0.0]} {RNA1509_22907} {RNA1310_5498.1, RNA1509_22907} {RNA1509_22907, RNA815_3951}
32. MligTC455_31074 50 1.04 Mlig455_061369

Neo: -

Age: -

MAN2C1 0.964 - - - - 0.964 - Mlig455_061369 {REF} {Length: 4885} {TRANSSPLICED} {Pfam: Glycosyl hydrolases family 38 N-terminal domain [PF01074.24, score=252.5]; Glycosyl hydrolases family 38 C-terminal domain [PF07748.15, score=92.6]; Alpha mannosidase middle domain [PF09261.13, score=67.9]} {Human: ENSG00000140400, MAN2C1, mannosidase alpha class 2C member 1, [RH, Score=611, Expect=0.0]} {Mouse: ENSMUSG00000032295, Man2c1, mannosidase, alpha, class 2C, member 1, [RH, Score=605, Expect=0.0]} {Smed: dd_Smed_v6_7449_0_11, dd_Smed_v6_7449_0_11, [RH, Score=734, Expect=0.0]} {RNA1509_13703} {RNA1310_2504.1, RNA1509_13703} {RNA1509_13703, RNA815_715}
33. MligTC455_17187 85 1.77 Mlig455_040722

Neo: -

Age: logFC(26M/2M)=-0.644

SCNN1B 0.963 - - - - 0.963 - Mlig455_040722 {REF} {Length: 2368} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.4]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=64.3, Expect=5e-10]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_25838_0_1, dd_Smed_v6_25838_0_1, [Score=230, Expect=3e-67]} {RNA1509_57515} {RNA1310_24808, RNA1509_57515} {RNA1509_57515, RNA815_46525}
34. MligTC455_48043 1751 36.48 Mlig455_017279, Mlig455_017291

Neo: -

Age: -

Region-enriched R7: 2.553/0.00000

Regeneration-downregulated BL: -2.231

Regeneration-depleted BL: -2.231

0.963 - - - - 0.963 -

Mlig455_017279 {REF} {Length: 4223} {RNA1509_52225} {RNA1310_3440.1} {RNA815_638.1}

Mlig455_017291 {REF} {Length: 3855} {RNA1509_3814, RNA1509_50356} {RNA1310_3440.1, RNA1509_50356} {RNA1509_50356, RNA815_638.1}
35. MligTC455_51179 75 1.55 Mlig455_068660

Neo: -

Age: -

WEE2 0.963 - - - - 0.963 - Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366}
36. MligTC455_14398 10 0.21 Mlig455_056592

Neo: -

Age: -

0.962 - - - - 0.962 - Mlig455_056592 {REF} {Length: 814} {NoTransDecoderORF}
37. MligTC455_16209 72 1.51 Mlig455_020329

Neo: -

Age: -

Region-enriched R2: 5.444/0.00658

0.962 - - - - 0.962 - Mlig455_020329 {REF} {Length: 2483} {Pfam: TIR domain [PF13676.8, score=38.4]; TIR domain [PF01582.22, score=29.5]; Domain of unknown function (DUF4481) [PF14800.8, score=20.4]} {Dmel: FBgn0032095, Toll-4, [RH, Score=53.1, Expect=7e-07]} {Smed: dd_Smed_v6_14454_0_1, dd_Smed_v6_14454_0_1, [RH, Score=270, Expect=2e-82]} {RNA1310_32445} {RNA815_27719}
38. MligTC455_52165 671 13.99 Mlig455_035531

Neo: -

Age: Down-Up-Up

Region-enriched R2: 5.972/0.00000
Region-enriched R3: 3.485/0.00346

0.962 - - - - 0.962 - Mlig455_035531 {REF} {Length: 648} {RNA1509_42191} {RNA1310_75398, RNA1509_42191} {RNA1509_42191, RNA815_40298}
39. MligTC455_25880 81 1.7 Mlig455_005910

Neo: -

Age: logFC(26M/2M)=-0.680

PRR9 0.961 - - - - 0.961 - Mlig455_005910 {REF} {Length: 2049} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=45.8, Expect=7e-06]} {RNA1509_54214} {RNA1310_38311.2} {RNA815_8809.1}
40. MligTC455_52348 196 4.08 Mlig455_050601

Neo: -

Age: logFC(26M/2M)=-0.400

0.961 - - - - 0.961 - Mlig455_050601 {REF} {Length: 3282} {Pfam: Spt20 family [PF12090.10, score=19.8]} {RNA1509_7271} {RNA1310_26412} {RNA815_23572}
41. MligTC455_24993 233 4.86 Mlig455_050468

Neo: -

Age: Up-Down-Down

PTPRS 0.959 - - - - 0.959 - Mlig455_050468 {REF} {Length: 2099} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=259.3]; Tyrosine phosphatase family [PF13350.8, score=26.7]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=20.1]} {Human: ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [Score=499, Expect=3e-164]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [Score=494, Expect=1e-163]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [Score=500, Expect=7e-167]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [Score=493, Expect=2e-162]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [Score=491, Expect=9e-163]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [Score=454, Expect=7e-146]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [Score=318, Expect=9e-100]} {Smed: dd_Smed_v6_9734_0_1, dd_Smed_v6_9734_0_1, [Score=439, Expect=8e-146]} {RNA1509_59220} {RNA1310_403.1} {RNA815_2245.3}
42. MligTC455_35694 30 0.63 Mlig455_022388

Neo: -

Age: -

WSCD2 0.959 - - - - 0.959 - Mlig455_022388 {REF} {Length: 1446} {Pfam: WSC domain [PF01822.21, score=47.1]; PAN domain [PF00024.28, score=21.9]; PAN domain [PF14295.8, score=19.3]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=51.6, Expect=3e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.4, Expect=7e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=52.8, Expect=9e-08]; ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=52.4, Expect=1e-07]} {RNA1310_119799} {RNA815_23500}
43. MligTC455_51177 76 1.59 Mlig455_058323

Neo: -

Age: Down-Up-Up

SAXO1 0.959 - - - - 0.959 - Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366}
44. MligTC455_49208 466 9.7 Mlig455_039543, Mlig455_051350

Neo: -

Age: -

Region-enriched R7: 3.047/0.01708

C17orf97, SELPLG 0.958 - - - - 0.958 -

Mlig455_039543 {REF} {Length: 1622} {Human: ENSG00000110876, SELPLG, selectin P ligand, [Score=68.2, Expect=3e-13]} {Celegans: WBGene00017794, mltn-13, MLt-TeN (Mlt-10) related, [Score=62.8, Expect=9e-12]} {RNA1310_47880} {RNA815_50555}

Mlig455_051350 {REF} {Length: 3453} {Human: ENSG00000283985, C17orf97, chromosome 17 open reading frame 97, [Score=59.7, Expect=5e-10]; ENSG00000187624, C17orf97, chromosome 17 open reading frame 97, [Score=59.7, Expect=5e-10]; ENSG00000110876, SELPLG, selectin P ligand, [Score=58.2, Expect=2e-09]} {Celegans: WBGene00017794, mltn-13, MLt-TeN (Mlt-10) related, [Score=53.5, Expect=3e-08]} {RNA1509_45595} {RNA1310_47880} {RNA815_50555}
45. MligTC455_40011 150 3.12 Mlig455_004436, Mlig455_004448

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.676

0.957 - - - - 0.957 -

Mlig455_004436 {REF} {Length: 595} {RNA1310_81676}

Mlig455_004448 {REF} {Length: 1192} {RNA1310_81676}
46. MligTC455_45881 285 5.94 Mlig455_051535

Neo: Irradiation

Age: Up-Down-Down

Region-enriched R2: 4.287/0.00883

CALM2 0.957 - - - - 0.957 - Mlig455_051535 {REF} {Length: 1911} {Pfam: EF-hand domain pair [PF13499.8, score=44.7]; EF-hand domain [PF14658.8, score=28.5]; EF-hand domain [PF13405.8, score=18.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=83.2, Expect=5e-18]; ENSG00000198668, CALM1, calmodulin 1, [Score=83.2, Expect=1e-18]; ENSG00000160014, CALM3, calmodulin 3, [Score=82.8, Expect=2e-18]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=82.8, Expect=1e-18]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=82.8, Expect=1e-18]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=82.8, Expect=1e-18]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.4, Expect=1e-18]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=82.4, Expect=1e-18]} {RNA1509_41430} {RNA1310_57772} {RNA815_28870}
47. MligTC455_00799 5 0.1 Mlig455_009712

Neo: -

Age: -

0.956 - - - - 0.956 - Mlig455_009712 {REF} {Length: 594} {NoTransDecoderORF} {RNA815_17525}
48. MligTC455_01762 8 0.17 Mlig455_065032

Neo: -

Age: -

0.956 - - - - 0.956 - Mlig455_065032 {REF} {Length: 627} {NoTransDecoderORF} {RNA1310_134975}
49. MligTC455_13318 468 9.76 Mlig455_037659

Neo: -

Age: -

0.955 - - - - 0.955 - Mlig455_037659 {REF} {Length: 2609} {Smed: dd_Smed_v6_20776_0_1, dd_Smed_v6_20776_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1509_12918, RNA1509_42831} {RNA1310_7526.1, RNA1509_42831} {RNA1509_42831, RNA815_9598.1}
50. MligTC455_25176 7 0.14 Mlig455_000293, Mlig455_067923

Neo: -

Age: Up-Down-Down

DYRK2 0.955 - - - - 0.955 -

Mlig455_000293 {REF} {Length: 2536} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=191.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=85.1]; Phosphotransferase enzyme family [PF01636.25, score=21.9]; ABC1 atypical kinase-like domain [PF03109.18, score=21.0]; RIO1 family [PF01163.24, score=18.9]} {Human: ENSG00000127334, DYRK2, dual specificity tyrosine phosphorylation regulated kinase 2, [RH, Score=620, Expect=0.0]} {Mouse: ENSMUSG00000028630, Dyrk2, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, [RH, Score=625, Expect=0.0]} {Dmel: FBgn0027101, Dyrk3, Dual-specificity tyrosine phosphorylation-regulated kinase 3, [RH, Score=543, Expect=0.0]} {Celegans: WBGene00003150, mbk-2, Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2, [RH, Score=561, Expect=0.0]} {Smed: dd_Smed_v6_10966_0_2, dd_Smed_v6_10966_0_2, [RH, Score=597, Expect=0.0]} {RNA1509_23467} {RNA1310_28330.1, RNA1509_23467} {RNA1509_23467, RNA815_20085}

Mlig455_067923 {REF} {Length: 480} {TRANSSPLICED} {Human: ENSG00000127334, DYRK2, dual specificity tyrosine phosphorylation regulated kinase 2, [Score=64.7, Expect=2e-12]; ENSG00000143479, DYRK3, dual specificity tyrosine phosphorylation regulated kinase 3, [Score=62.8, Expect=5e-12]} {Mouse: ENSMUSG00000028630, Dyrk2, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, [Score=71.2, Expect=9e-15]} {Dmel: FBgn0027101, Dyrk3, Dual-specificity tyrosine phosphorylation-regulated kinase 3, [Score=56.2, Expect=1e-09]} {Smed: dd_Smed_v6_10045_0_1, dd_Smed_v6_10045_0_1, [Score=67.4, Expect=7e-14]} {RNA1509_23467} {RNA1310_28330.2} {RNA815_20085}
51. MligTC455_01654 34 0.71 Mlig455_025189

Neo: -

Age: -

0.953 - - - - 0.953 - Mlig455_025189 {REF} {Length: 577} {NoTransDecoderORF} {RNA1509_16128} {RNA1310_76847} {RNA815_29511.2}
52. MligTC455_05969 143 2.98 Mlig455_008036, Mlig455_008076

Neo: -

Age: Up-Down-Up

CHRM3 0.953 - - - - 0.953 -

Mlig455_008036 {REF} {Length: 4356} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=235.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=49.3]; Olfactory receptor [PF13853.8, score=29.1]} {Human: ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [Score=252, Expect=3e-75]} {Mouse: ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [Score=248, Expect=3e-74]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [RH, Score=216, Expect=9e-61]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [RH, Score=246, Expect=2e-73]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [RH, Score=243, Expect=3e-73]} {RNA1509_25623} {RNA1310_4787.1} {RNA815_38888}

Mlig455_008076 {REF} {Length: 6010} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=260.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=48.6]; Olfactory receptor [PF13853.8, score=28.2]} {Human: ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [RH, Score=306, Expect=1e-95]} {Mouse: ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [RH, Score=302, Expect=3e-94]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [RH, Score=215, Expect=4e-60]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [RH, Score=307, Expect=2e-96]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [RH, Score=303, Expect=1e-95]} {RNA1509_25623} {RNA1310_4787.1, RNA1509_25623} {RNA1509_25623, RNA815_17017}
53. MligTC455_57023 35 0.72 Mlig455_025177

Neo: -

Age: -

0.953 - - - - 0.953 - Mlig455_025177 {REF} {Length: 323} {NoTransDecoderORF} {RNA1509_16128} {RNA1310_99479.1} {RNA815_29511.2}
54. MligTC455_19795 50 1.05 Mlig455_015163, Mlig455_015285

Neo: -

Age: Up-Down-Down

0.952 - - - - 0.952 -

Mlig455_015163 {REF} {Length: 4537} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.2]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=7e-119]} {RNA1509_44797} {RNA1310_13221} {RNA815_45407}

Mlig455_015285 {REF} {Length: 4094} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=9e-119]} {RNA1509_57431} {RNA1310_13221} {RNA815_45407}
55. MligTC455_53957 80 1.66 Mlig455_068224

Neo: -

Age: Up-Down-Up

0.952 - - - - 0.952 - Mlig455_068224 {REF} {Length: 3283} {RNA1310_18298} {RNA815_25523}
56. MligTC455_22660 19 0.4 Mlig455_053247

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_053247 {REF} {Length: 614} {NoTransDecoderORF} {RNA1310_34478}
57. MligTC455_24992 222 4.62 Mlig455_040423

Neo: -

Age: Up-Down-Down

PTPRD 0.951 - - - - 0.951 - Mlig455_040423 {REF} {Length: 5511} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=536.0]; Fibronectin type III domain [PF00041.23, score=69.6]; Tyrosine phosphatase family [PF13350.8, score=37.9]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=33.7]; Inositol hexakisphosphate [PF14566.8, score=24.3]} {Human: ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [RH, Score=1010, Expect=0.0]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [RH, Score=1009, Expect=0.0]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [RH, Score=1023, Expect=0.0]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [RH, Score=1011, Expect=0.0]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [RH, Score=1004, Expect=0.0]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [RH, Score=928, Expect=0.0]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [RH, Score=723, Expect=0.0]} {Smed: dd_Smed_v6_10176_0_2, dd_Smed_v6_10176_0_2, [RH, Score=962, Expect=0.0]} {RNA1509_45823, RNA1509_59220} {RNA1310_2694.1, RNA1509_45823, RNA1509_59220} {RNA1509_45823, RNA1509_59220, RNA815_2245.1}
58. MligTC455_48320 81 1.69 Mlig455_008829

Neo: -

Age: Down-Down-Up

TOB1 0.951 - - - - 0.951 - Mlig455_008829 {REF} {Length: 832} {Pfam: BTG family [PF07742.14, score=62.3]} {Human: ENSG00000141232, TOB1, transducer of ERBB2, 1, [Score=64.7, Expect=2e-12]} {Mouse: ENSMUSG00000037573, Tob1, transducer of ErbB-2.1, [Score=63.2, Expect=4e-12]} {Dmel: FBgn0028397, Tob, [Score=68.6, Expect=5e-14]} {Smed: dd_Smed_v6_7444_0_1, dd_Smed_v6_7444_0_1, [Score=75.1, Expect=5e-17]} {RNA1509_42403, RNA1509_59615} {RNA1310_49803, RNA1509_42403, RNA1509_59615}
59. MligTC455_22501 73 1.51 Mlig455_036417

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.645

SLC6A4 0.95 - - - - 0.950 - Mlig455_036417 {REF} {Length: 3681} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=681.8]} {Human: ENSG00000108576, SLC6A4, solute carrier family 6 member 4, [RH, Score=610, Expect=0.0]} {Mouse: ENSMUSG00000020838, Slc6a4, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4, [RH, Score=599, Expect=0.0]} {Dmel: FBgn0010414, SerT, Serotonin transporter, [RH, Score=631, Expect=0.0]} {Celegans: WBGene00003387, mod-5, Transporter, [RH, Score=559, Expect=0.0]} {Smed: dd_Smed_v6_12700_0_1, dd_Smed_v6_12700_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_33614} {RNA1310_10815, RNA1509_33614} {RNA1509_33614, RNA815_8003}
60. MligTC455_37682 225 4.68 Mlig455_022978, Mlig455_023072

Neo: -

Age: Up-Down-Up

Region-enriched R7: 2.657/0.03586

KCNN2 0.95 - - - - 0.950 -

Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768}

Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768}
61. MligTC455_53118 133 2.76 Mlig455_029477

Neo: -

Age: -

CHRNA2 0.95 - - - - 0.950 - Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA